Mesoblast share price logo

Mesoblast

NASDAQ: MESO

Mid Cap

$15.60

-0.89

(-5.43%)

as on

Mesoblast Stock Performance

as on August 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $15.40
    $15.68
    downward going graph

    1.28%

    Downside

    0.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.66
    $21.50
    downward going graph

    18.85%

    Downside

    37.82%

    Upside

    downward going graph

Mesoblast share price movements today

Previous Close
$16.49
Open
$15.68
Volume
250.8K
Market Cap
$2.0B
Day's Low - High
$15.40 - $15.68
52 Week Low - High
$12.66 - $21.50

Mesoblast Historical Returns

1 Month Return
-9.96 %
3 Month Return
+ 4.04 %
1 Year Return
-4.03 %
3 Year Return
+ 533.94 %
5 Year Return
+ 10.6 %

Mesoblast Stock Fundamentals & Key Indicators

Check Mesoblast market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-0.46

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-64.3M

Revenue (TTM)

65.4M

Profit Margin

-144.33%

Return On Equity TTM

-18.22%

Mesoblast vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mesoblast with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.0B10.6%NA-144.33%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Mesoblast Stock including INR - Dollar returns

The Mesoblast stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mesoblast investment value today

Current value as on today

₹1,05,105

Returns

₹5,105

(+5.11%)

Returns from Mesoblast Stock

-₹4,000 (-4%)

Dollar Impact

₹9,105 (+9.11%)

Analyst Recommendation on Mesoblast Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Mesoblast. Average target price of $35

Mesoblast Share Price Target

Get share price movements and forecasts by analysts on Mesoblast.

What analysts predicted

55.43%UPSIDE

Target Price

$35

Current Price

$15.6

Analyzed by

9 Analysts

Target

$35.00

Mesoblast target price $35, a slight upside of 55.43% compared to current price of $15.6. According to 9 analysts rating.

Indian Investors' Interest in Mesoblast Stock

Search interest for Mesoblast Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:66% versus previous 30 day period

Mesoblast Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1
1
1
1
1
1
7
7
25
25
Gross Profit
-8
-8
-9
-9
-1
-1
-16
-16
-1
-1
Operating Income
-20
-20
-22
-22
-20
-20
-34
-34
-38
-38
EBITDA
-12
-12
-15
-15
-9
-9
-19
-19
-12
-12
Interest Expense
5
5
4
4
5
5
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-16
-16
-27
-27
-23
-23
-27
-27
-19
-19
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-16
-16
-27
-27
-23
-23
-27
-27
-20
-20
Net Profit Margin
-960.42%
-960.42%
-2204.34%
-2204.34%
-1518.82%
-1518.82%
-386.04%
-386.04%
-78.22%
-78.22%

Mesoblast Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
42
2
17
16
32
7
10
7
5
17
Gross Profit
12
-9
11
-58
-49
-78
-53
-47
-35
12
Operating Income
-55
-90
-77
-80
-74
-109
-80
-69
-84
-62
EBITDA
-28
-87
-74
-84
-68
-84
-76
-58
-56
-73
Interest Expense
9
-
1
11
14
10
17
19
20
22
Depreciation
-
3
2
2
3
4
4
4
4
6
Income Before Tax
-90
-90
-65
-98
-87
-99
-91
-82
-88
-101
Income Tax Expense
-86
-13
-30
-8
-9
0
0
0
0
0
Net Income
-4
-76
-35
-89
-77
-98
-91
-81
-87
-102
Net Profit Margin
-9.70%
-3184.70%
-203.51%
-537.01%
-242.38%
-1325.25%
-894.59%
-1091.71%
-1490.27%
-593.92%

Mesoblast Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-27
-23
-23
-27
-27
-
-
-
Operating Cash Flow
-11
-10
-10
-10
-12
-16
-14
-15
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
11
-3
-1
-2
156
-4
-1
0
-4
Change in Cash
-1
-13
-11
-13
144
-20
-16
-14
-8

Mesoblast Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-76
-35
-89
-77
-98
-91
-81
-87
-102
Operating Cash Flow
-95
-75
-57
-56
-106
-65
-63
-48
-49
Investing Cash Flow
0
-1
-1
-3
-1
0
0
0
0
Financing Cash Flow
60
68
71
137
114
-9
74
40
147
Change in Cash
-35
-7
12
78
7
-76
10
-8
98

Mutual Funds that own Mesoblast Stock

Check out the Mutual Funds with significant holdings in Mesoblast.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.023666%
30737
Steward Funds Inc
0.00501%
6507
DFA INVESTMENT DIMENSIONS GROUP INC
0.000612%
796

Global Institutional Holdings in Mesoblast

Funds
Holdings
iShares
0.46%
Invesco
0.01%
ActivePassive
0.01%
Xtrackers
0%
ProShares
0%

Insights on Mesoblast

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -27.10M → -20.08M (in $), with an average increase of 17.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 7 quarters, 1.25M → 25.67M (in $), with an average increase of 28.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 464.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.5% return, outperforming this stock by 61.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MESO stock has moved down by -6.5%

About Mesoblast

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Remestemcel-L, which is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease and biologic refractory inflammatory bowel disease, as well as ulcerative colitis and Crohn's disease; and Remestemcel-L, which is in Phase III clinical trials to treat chronic heart failure and chronic low back pain due to degenerative disc disease. The company is also developing MPC-300-IV to treat biologic refractory rheumatoid arthritis diabetic nephropathy. It has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for the treatment or prevention of chronic heart failure; MPC-25-IC for the treatment or prevention of acute myocardial infarction; and Ryoncil for the treatment of pediatric SR-aGVHD; JCR Pharmaceuticals Co. Ltd. to treat wound healing in patients with epidermolysis bullosa and for the treatment of neonatal hypoxic ischemic encephalopathy; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. The company was incorporated in 2004 and is headquartered in Melbourne, Australia.
OrganisationMesoblast
Headquarters55 Collins Street, Melbourne, VIC, Australia, 3000
IndustryBiotechnology
CEODr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
E-voting on sharesClick here to vote

Key Management of Mesoblast

Name

Title

Mr. Daniel Devine B.Sc., J.D., M.B.A

Head of Special Projects

Dr. Fiona See Ph.D.

Senior VP & Head of Translational Research

Ms. Geraldine Storton B.Sc., M.B.A., MMS

Head of Regulatory Affairs & Quality Management

Dr. Eric A. Rose M.D.

Chief Medical Officer & Executive Director

Mr. James Michael O'Brien CPA, M.B.A.

Chief Financial Officer

Mr. Paul Hughes BPHARM

Global Head of Corporate Communications & Joint Company Secretary

Mr. Anthony Wheal

Head of Human Resources

Dr. Paul J. Simmons BSc, Ph.D.

Scientific Advisor to the Chief Executive Officer

Mr. Justin Horst B.S.

Head of Manufacturing

Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)

Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director

FAQs

What is Mesoblast share price today?

Mesoblast share price today is $15.60 as on at the close of the market. Mesoblast share today touched a day high of $15.68 and a low of $15.40.

What is the 52 week high and 52 week low for Mesoblast share?

Mesoblast share touched a 52 week high of $21.50 on and a 52 week low of $12.66 on . Mesoblast stock price today i.e. is closed at $15.60,which is 27.44% down from its 52 week high and 23.22% up from its 52 week low.

What is Mesoblast's market capitalisation today?

Mesoblast market capitalisation is $0.00T as on .

How to invest in Mesoblast Stock (MESO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mesoblast on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mesoblast Shares that will get you 0.0962 shares as per Mesoblast share price of $15.60 per share as on August 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Mesoblast Stock (MESO) from India?

Indian investors can start investing in Mesoblast (MESO) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Mesoblast stock (as per the Rupee-Dollar exchange rate as on ). Based on Mesoblast share’s latest price of $15.60 as on August 17, 2026 at 8:45 am IST, you will get 0.6410 shares of Mesoblast. Learn more about fractional shares .

What are the returns that Mesoblast has given to Indian investors in the last 5 years?

Mesoblast stock has given 10.6% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?